IRIS

Sfoglia per Rivista  DIABETES

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Mostrati risultati da 1 a 20 di 90
Titolo Data di pubblicazione Autore(i) File
Adipokines: The Missing Link between Alzheimer's Disease and Type 2 Diabetes? 1-gen-2014 Mitrea, A; Fallucca, S; Angeletti, S
Age-Period-Cohort Analysis of 1990-2003 Incidence Time Trends of Childhood Diabetes in Italy The RIDI Study 1-gen-2010 Bruno, G; Maule, M; Merletti, F; Novelli, G; Falorni, A; Iannilli, A; Iughetti, L; Altobelli, E; D'Annunzio, G; Piffer, S; Pozzilli, P; Iafusco, D; Songini, M; Roncarolo, F; Toni, S; Carle, F; Cherubini, V
AUTOANTIBODIES IN NEWLY-DIAGNOSED IDDM SERA DETECTED USING A HUMAN INSULINOMA CELL-LINE AS SUBSTRATE 1-gen-1994 Cavallo, Mg; Monetini, L; Valente, L; Desantis, R; Pozzilli, P
B7-H4.Ig inhibits human beta-cell destruction mediated by beta cell-specific cytotoxic T cells derived from patients with type 1 diabetes 1-gen-2005 Ou, D; Wang, X; Metzger, Dl; Ao, Z; Pozzilli, P; Chen, L; Warnock, Gl.
beta-cell antigen-specific CD56(+) NKT cells from type 1 diabetes patients: Autoaggressive effector T cells damage human CD56+p cells by HLA-Restricted and Non-HLA-Restricted pathways 1-gen-2001 Ou, Dw; Metzger, D; Wang, Xj; Pozzilli, P; Tingle, A
Blue eyes and fair skin are risk factors for type 1 diabetes in the Mediterranean region 1-gen-2007 Maggi, D; Berardesca, E; Marulli, G; Manfrini, S; Bizzarri, C; Lauria, A; Pitocco, D; Pozzilli, P
BMI is the major driver of beta cell loss in recent onset type 1 diabetes: a multicentre longitudinal study 1-gen-2012 Barker, A; Lauria, A; Schloot, N; Hosszufalusi, N; Panczel, P; Ludvigsson, J; Mathieu, C; Mauricio, D; Rubinat, E; Norwall, M; Schueren, B; Mandroup-Poulsen, T; Scherboum, W; Wareham, N; Weets, I; Gorus, F; Leslie, D; Pozzilli, P
Buccal Spray Insulin for the Management of Post-Prandial Hyperglycaemia in Subjects with Impaired Glucose Tolerance 1-gen-2009 Palermo, A; Pozzilli, P; Napoli, N; Costanza, F; Beretta, G; Manfrini, S.
C-peptide and HbA1c levels at diagnosis indicate a different pathogenic process depending on the age of onset of type 1 diabetes 1-gen-2004 Pozzilli, P; Visalli, N; Picardi, A; Manfrini, S; Crino, A; Suraci, C; Pitocco, D; Ghirlanda, G; Patera, P
C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop (vol 53, pg 250, 2004) 1-gen-2004 Palmer, Jp; Fleming, Ga; Greenbaum, Cj; Herold, Kc; Jansa, Ld; Kolb, H; Lachin, Jm; Polonsky, Ks; Pozzilli, P; Skyler, Js; Steffes, Mw
C-Peptide Response and HLA Genotypes in Subjects with Recent Onset Type 1 Diabetes Following Immunotherapy with Diapep277 1-gen-2009 Buzzetti, R; Cernea, S; Petrone, A; Spoletini, M; Zampetti, S; Guglielmi, C; Venditti, C; Pozzilli, P
C-peptide Response and HLA Genotypes in Subjects With Recent-Onset Type 1 Diabetes After Immunotherapy With DiaPep277 An Exploratory Study 1-gen-2011 Buzzetti, R; Cernea, S; Petrone, A; Capizzi, M; Spoletini, M; Zampetti, S; Guglielmi, C; Venditti, C; Pozzilli, P
CA2 Gene Polymorphisms Are Associated with Specific Eye Colour and Skin Phenotype in Type 1 Diabetes 1-gen-2010 Spoletini, M; Maggi, D; Zampetti, S; Astorri, E; Buzzetti, R; Pozzilli, P; Imdiab, G
Calcitriol and bone turnover in Type 1 diabetic adolescents 1-gen-2012 Napoli, N; Strollo, R; Pitocco, D; Bizzarri, C; Maddaloni, E; Maggi, D; Manfrini, S; Schwartz, A; Pozzilli, P; Imdiab, Group
Cellular immune response to multiple cow milk proteins in IDDM 1-gen-1998 Cavallo, Mg; Monetini, L; Barone, F; Valente, L; Pozzilli, P; Grp, I
Characterising islet protein tyrosine phosphatase antibodies association with type 1 diabetes 1-gen-1996 Leslie, D; Hawa, M; Rowe, R; Lan, M; Notkins, A; Pozzilli, P
A common mutation in the Insulin Receptor Substrate-1 gene is a genetic marker for the Insulin Resistance Syndrome in patients with coronary artery disease 1-gen-1998 Baroni, Mg; Arca, M; D'Andrea, Mp; Campagna, F; Capici, F; Urbinati, G; Pozzilli, P
Conversation maps: th path thowards self-management 1-gen-2012 Khazray, Mh; Defeudis, G; Cutolo, S; Pasqualotto, E; Pozzilli, P; Manfrini, S
CSII versus intensive insulin therapy at onset of type 1 diabetes: The IMDIAB 8 two-year randomised trial 1-gen-2002 Manfrini, S; Crino, A; Fredrickson, L; Pozzilli, P
Cytoprotection of pancreatic beta cells by co-overexpression of Bcl-2 and XIAP genes blocking TRAIL-mediated death-signal transduction pathways 1-gen-2004 Ou, Dw; Wang, Xj; Metzger, Dl; James, Rfl; Pozzilli, P; Plesner, A; Korneluk, Rg; Verchere, Cb; Tingle, Aj
Mostrati risultati da 1 a 20 di 90
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile